EA202191610A1 - Композиции, полученные из сконструированного флагеллина, и их применение - Google Patents
Композиции, полученные из сконструированного флагеллина, и их применениеInfo
- Publication number
- EA202191610A1 EA202191610A1 EA202191610A EA202191610A EA202191610A1 EA 202191610 A1 EA202191610 A1 EA 202191610A1 EA 202191610 A EA202191610 A EA 202191610A EA 202191610 A EA202191610 A EA 202191610A EA 202191610 A1 EA202191610 A1 EA 202191610A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- flagellin
- constructed
- application
- compositions obtained
- deimmunized
- Prior art date
Links
- 108010040721 Flagellin Proteins 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 abstract 1
- 108010034143 Inflammasomes Proteins 0.000 abstract 1
- 102100039357 Toll-like receptor 5 Human genes 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862776507P | 2018-12-07 | 2018-12-07 | |
| PCT/US2019/064954 WO2020118192A1 (en) | 2018-12-07 | 2019-12-06 | Engineered flagellin-derived compositions and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202191610A1 true EA202191610A1 (ru) | 2021-10-25 |
Family
ID=70974397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202191610A EA202191610A1 (ru) | 2018-12-07 | 2019-12-06 | Композиции, полученные из сконструированного флагеллина, и их применение |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220024991A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3890769A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022511881A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210111770A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113382742A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019392903A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3122067A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202191610A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283757A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020118192A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102720967B1 (ko) * | 2020-06-04 | 2024-10-23 | 가톨릭대학교 산학협력단 | 플라젤린으로부터 유도된 tlr5 작용제를 유효성분으로 포함하는 면역관문억제제의 항암 효과 증진용 약학 조성물 |
| CN119522108A (zh) * | 2022-06-01 | 2025-02-25 | 弗莱格生物公司 | Rna佐剂、其方法和用途 |
| KR102896818B1 (ko) * | 2022-10-19 | 2025-12-08 | 전남대학교 산학협력단 | Tlr5 활성능을 가진 플라젤린 면역증강제 유도체의 진핵세포 발현시스템을 이용한 제조 및 응용 |
| KR20240081501A (ko) * | 2022-11-14 | 2024-06-10 | 전남대학교산학협력단 | 암의 치료용 면역증강 살모넬라 균주 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2121734B1 (en) * | 2007-02-09 | 2013-05-08 | Industry Foundation of Chonam National University | Modified flagellin improved toll-like receptor 5 stimulating activity |
| US9376495B2 (en) * | 2011-05-21 | 2016-06-28 | Macrogenics, Inc. | Deimmunized serum-binding domains and their use in extending serum half-life |
| CA2903252C (en) * | 2013-03-14 | 2023-01-17 | Research Corporation Technologies, Inc. | Ribotoxin molecules derived from sarcin and other related fungal ribotoxins |
| EP3174893B1 (en) * | 2014-07-30 | 2020-05-06 | Genome Protection, Inc. | Flagellin compositions and uses |
-
2019
- 2019-12-06 EA EA202191610A patent/EA202191610A1/ru unknown
- 2019-12-06 EP EP19892798.0A patent/EP3890769A4/en not_active Withdrawn
- 2019-12-06 CN CN201980090594.0A patent/CN113382742A/zh active Pending
- 2019-12-06 US US17/299,373 patent/US20220024991A1/en not_active Abandoned
- 2019-12-06 CA CA3122067A patent/CA3122067A1/en active Pending
- 2019-12-06 WO PCT/US2019/064954 patent/WO2020118192A1/en not_active Ceased
- 2019-12-06 JP JP2021532369A patent/JP2022511881A/ja active Pending
- 2019-12-06 AU AU2019392903A patent/AU2019392903A1/en not_active Abandoned
- 2019-12-06 KR KR1020217021065A patent/KR20210111770A/ko not_active Ceased
-
2021
- 2021-06-06 IL IL283757A patent/IL283757A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3122067A1 (en) | 2020-06-11 |
| US20220024991A1 (en) | 2022-01-27 |
| IL283757A (en) | 2021-07-29 |
| CN113382742A (zh) | 2021-09-10 |
| AU2019392903A1 (en) | 2021-06-24 |
| JP2022511881A (ja) | 2022-02-01 |
| EP3890769A4 (en) | 2022-11-23 |
| EP3890769A1 (en) | 2021-10-13 |
| KR20210111770A (ko) | 2021-09-13 |
| WO2020118192A1 (en) | 2020-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA202091508A1 (ru) | 6-азаиндольные соединения | |
| CY1122740T1 (el) | Ευτηκτικα σκευασματα υδροχλωρικης κυκλοβενζαπρινης και μαννιτολης | |
| JOP20200122A1 (ar) | مركبات مفيدة لتثبيط cdk7 | |
| EA202190377A9 (ru) | Композиции ингибиторов cxcr4 и способы получения и применения | |
| MX2018000542A (es) | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. | |
| MA39362A1 (fr) | Compositions stables d'iode non complexé et procédés d'utilisation. | |
| CY1124425T1 (el) | Συνθεσεις οι οποιες περιλαμβανουν συζευγματα φαρμακου αντισωματος-δουοκαρμυκινης | |
| EA201690962A1 (ru) | Составы | |
| EA201692177A1 (ru) | Соединения и композиции в качестве агонистов toll-подобного рецептора 7 | |
| EA202190960A1 (ru) | Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30) | |
| CY1124338T1 (el) | Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων | |
| MX387402B (es) | Formulaciones eutécticas de clorhidrato de ciclobenzaprina. | |
| EA201891644A1 (ru) | Антибактериальные соединения и их применение | |
| JOP20210004A1 (ar) | عوامل تحلّل مستقبلات الإستروجين الانتقائية | |
| MX391414B (es) | Compuesto novedoso de bifenilo o sal del mismo. | |
| EA201692043A1 (ru) | Лекарственная форма иммунодепрессанта | |
| MX389724B (es) | Compuestos de fenil-2-hidroxi-acetilamino-2-metil-fenilo | |
| EA201892822A1 (ru) | Новые антибактериальные соединения | |
| MX394123B (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos | |
| EA201791454A1 (ru) | Лекарственные формы для трансдермального введения | |
| EA201991377A1 (ru) | Композиции универсальной вакцины против гриппа | |
| EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| EA201792000A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| MX2020005483A (es) | Antagonistas de ildr2 y combinaciones de los mismos. | |
| EA201892837A1 (ru) | Физиологически сбалансированные составы для инъекций, включающие фоснетупитант |